Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
Dominik Paul Modest(Ludwig-Maximilians-Universität München), Ingrid Ricard, Volker Heinemann(Heidelberg University), S. Hegewisch-Becker(HOPE Clinic), Wolff Schmiegel(Universitätsklinikum Knappschaftskrankenhaus Bochum), Rainer Porschen(Klinikum Bremen-Mitte), Sebastian Stintzing(Heidelberg University), Ullrich Graeven(Kliniken Maria Hilf), Dirk Arnold, Ludwig Fischer von Weikersthal(Klinikum St. Marien Amberg), Clemens Gießen-Jung(Ludwig-Maximilians-Universität München), Arndt Stahler(Ludwig-Maximilians-Universität München), Hans‐Joachim Schmoll(University Hospital in Halle), Andreas Jung(Heidelberg University), Thomas Kirchner(Heidelberg University), Andrea Tannapfel(Ruhr University Bochum), Anke Reinacher‐Schick(Ruhr University Bochum)
Cited by 344Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis